The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis
Magdalena Ruth Moshi, Konstance Nicolopoulos, Danielle Stringer, Ning Ma, Mathias Jenal, Thomas Vreugdenburg
Topics & Concepts
DenosumabMedicineRaloxifeneSelective estrogen receptor modulatorPlaceboOsteoporosisInternal medicineRandomized controlled trialAdverse effectDiscontinuationOncologyUrologyBreast cancerTamoxifenCancerPathologyAlternative medicineBone health and osteoporosis researchBone health and treatmentsBone Metabolism and Diseases